Increase of interleukin 6 and decrease of interleukin 2 production during the ageing process are influenced by the health status

Mechanisms of Ageing and Development

Volumn 100, Issue 3, 1998, Pages 313-328

  Myśliwska, Jolanta ^a   Bryl, Ewa ^a   Foerster, Jerzy ^b   Myśliwski, Andrzej ^a  

^a MEDICAL UNIVERSITY OF GDANSK   (Poland)

^b Geriatric Outpatient's Department   (Poland)

Author keywords

Ageing; Health status; IL2; IL6

Indexed keywords

CYTOKINE; INTERLEUKIN 2; INTERLEUKIN 6; MESSENGER RNA;

ADULT; AGED; AGING; ARTICLE; BIOASSAY; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; GENE ACTIVITY; HEALTH STATUS; HUMAN; HUMAN EXPERIMENT; MALE; MONONUCLEAR CELL; NORMAL HUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADULT; AGED; AGING; FEMALE; GENE EXPRESSION; HEALTH STATUS; HUMANS; INTERLEUKIN-2; INTERLEUKIN-6; MALE; MIDDLE AGED;

EID: 0344269351     PISSN: 00476374     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0047-6374(97)00154-1     Document Type: Article

References (46)

1. Barton B.E. The biological effects of interleukin 6. Med. Res. Rev. 16:1996;87-109.
2. Belmin J., Bernard C., Corman B., Merval R., esposito B., Tedgui A. Increased production of Tumor Necrosis Factor and Interleukin-6 by arterial wall of aged rats. Am. J. Physiol. 268:1995;H2288-H2293.
3. Caruso C., Di Lorenzo G., Modica M.A., Candore G., Portelli M.R., Crescimanno G., Ingrassia A., Sangiorgi G.B., Salerno A. Soluble interleukin-2 receptor release defect in vitro in elderly subjects. Mech. Ageing Dev. 59:1991;27-35.
4. Chan Y.C., Suzuki M., Yamamoto S. Nutritional status of centenarians assassed by activity and anthropometric, hematological and biochemical characteristics. J. Nutr. Sci. Vitaminol. 43:1997;73-81.
5. Chopra R.K., Holbrook N.J., Powers D.C., McCoy M.T., Adlerand W.H., Nagel J.E. Interleukin-2, Interleukin-2 receptor and interferon γ synthesis and mRNA expression in PMA and A23187 stimulated T cells from elderly humans. Clin. Immunol. Immunpathol. 53:1989;297-308.
6. Duits A.J., Dimjati W., Van de Winkel J.G., Capel P.J. Synergism of interleukin 6 and 1 alpha-25 dihydroxyvitamin D3 in induction of myeloid differentiation of human leukemic cell lines. J. Leukoc. Biol. 51:1992;237-243.
7. Ernst D.N., Weigle W.O., Hobbs M.V. Aging and lymphokine production by T cell subsets. Stem Cells. 11:1993;487-498.
8. Ershler W.B., Sun W.H., Binkley N., Gravenstein S., Volk M.J., Kamoske G., Klopp R.G., Roecker E.B., Daynes R.A., Weindruch R. Interleukin-6 and aging: blood levels and mononuclear cell production increase with advancing age and in vitro production is modifiable by dietary restriction. Lymphokine Cytokine Res. 12:1993;225-230.
9. Fagiolo U., Cossarizza A., Scala E., Fanales-Belasio E., Ortolani C., Cozzi E., Monti D., Franceschin C., Paganelli R. Increased cytokine production in mononuclear cells of healthy elderly people. Eur. J. Immunol. 23:1993;2375-2378.
10. Frey J.R., Kamber M., Peck R. Recombinant interferons or interleukin-2 increase cytotoxicity by human monocytes and NK cells. Lymphokine Res. 6:1987;215-227.
11. Galandrini R., Cernetti C., Albi N., Dembech C., Terenzi A., Grignari F., Verlardi A. Interleukin 6 is constitutively produced by human CTL clones and is required to maintain their cytolytic function. Cell. Immunol. 138:1991;11-23.
12. Glowacki J. Influence of age on human marrow. Calcif. Tissue Int. 56(Suppl.1):1995;S50-S51.
13. Hager K., Machein U., Krieger S., Platt D., Seefried G., Bauer J. Interleukin-6 and selected plasma proteins in healthy persons of different ages. Neurobiol. Aging. 15:1994;771-772.
14. Hansen M.B., Svenson M., Diamant M., Abell K., Bendtzen K. Interleukin-6 autoantibodies possible biological and clinical significance. Leukemia. 9:1995;1113-1115.
15. Hara H., Tanaka T., Negoro S., Deguchi Y., Saiki O., Kishimoto S. Age-related changes of expression of IL2-receptor subunits and kinetics of IL2 internalisation in T cells after mitogenic stimulation. Mech. Ageing Dev. 45:1988;167-175.
16. Hirokawa K., Utsuyama M., Kasai M., Kurashima C. Aging and immunity. Acta Pathol. Jpn. 42:1992;537-548.
17. Horan M.A., Fox R.A. Ageing and immune response: a unifying hypothesis. Mech. Ageing Dev. 26:1984;165-181.
18. Kawano M., Hirano T., Matsuda T., Taga T., Hirri Y., Iwato K., Asaoku H., Tang B., Tang O., Tanaka H.et al. Autocrine generation and requirement of BSF-2/IL6 for human multiple myelomas. Nature. 332:1988;83-85.
19. Kuhweide R., Van Damme J., Lorre K., Baroja M.L., Tsudon M., L Ceuppens J. Accessory cell-derived helper signals in human T-cell activation with phytohemagglutinin, induction of interleukin 2, responsiveness by interleukin 6 and production of interleukin 2 by interleukin 1. Cytokine. 2:1990;45-54.
20. Lahat N., Aghai E., Maronn B. Increased spontaneous secretion of IL6 from B cells of patients with chronic lymphatic leukemia (B-CLL) and autoimmunity. Clin. Exp. Immunol. 85:1991;302-306.
21. Ligthart G.J., Corberand J.X., Fournier C., Galanaud P., Hijmans W., Kennes B., Muller-Hermelink H.K., Steinmann G.G. Admission criteria for immunogerontological studies in man: the Senieur protocol. Mech. Ageing Dev. 28:1984;47-55.
22. Mariotti S., Sansoni P., Barbesino G., Caturegli P., Monti D., Cossarizza A., Giacomelli T., Passeri G., Fagiolo U., Pinchera A. Thyroid and other organ-specific autoantibodies in healthy centenarians. Lancet. 239:1992;1506-1508.
23. Meyer K.C., Ershler W., Rosenthal N.S., Lu X.G., Peterson K. Immune dysregulation in the aging human lung. Am. J. Respir. Crit. Care Med. 153:1996;1072-1079.
24. Morinaga Y., Suzuki H., Takatsuki F., Akiyama Y., Taniyama T., Matsushima K., Onozaki K. Contribution of IL-6 to the antiproliferative effect of IL-1 and tumor necrosis Factor on tumor cell lines. J. Immunol. 143:1989;3538-3542.
25. Mukaida N., Mahe Y., Matsushima K. Cooperative interaction of nuclear factor kappa B and cis-regulator enhancer binding protein-like factor binding elements in activity the interleukin 8 gene by proinflammatory cytokines. J. Biol. Chem. 265:1990;2128-2133.
26. Myśliwska J., Bryl E., Zorena K., Foerster J., Myśliwski A. Overactivity of TNFα but not IL6 is associated with low NK cytotoxic activity in the elderly. Gerontology. 43:1997;158-167.
27. Natsuka S., Akira S., Nishio Y., Hashimoto S., Sugita T., Isshiki H., Kishimoto T. Macrophage differentiation-specific expression of NF-IL6, a transcription factor for IL6. Blood. 79:1992;460-466.
28. Radl J., Sepers J.M., Skvaril F. Immunological pattern in humans over 95 years of age. Clin. Exp. Immunol. 22:1975;84-90.
29. Rea I.M., Stewart M., Campbell P., Alexander H.D., Crockard A.D., Morris T.C.M. Changes in lymphocyte subsets, Interleukin 2, and suluble Interleukin 2 receptor in old and very old age. Gerontology. 42:1996;69-78.
30. Riordan S.M., McIver C.J., Wakefield D., Duncombe V.M., Bolin T.D., Thomas M.C. Mucosal cytokine production in small-intestinal bacterial overgrowth. Scand. J. Gastroenterol. 31:1996;977-984.
31. Roghmann K.J., Tabloski P.A., Bentley D.W., Schiffman G. Immune response of elderly adults to pneumococcus, variation by age, sex, and functional impairment. J. Gerontol. 3:1987;265-270.
32. Rus H.G., Vlaicu R., Niculescu F. Interleukin-6 and interleukin-8 protein and gene expression in human arterial atherosclerotic wall. Atherosclerosis. 127:1996;263-271.
33. Sanceau J., Falcoff R., Beranger F., Carter D.B., Wietzerbin J. Secretion of interleukin 6 (IL6) by human monocytes stimulated by muramyl dipeptide and tumor necrosis factor alpha. Immunology. 69:1990;52-56.
34. Shalaby M.R., Waage A., Aarden L., Espevik T. Endotoxin, tumor necrosis factor α and interleukin 1 induce interleukin 6 production in vivo. Clin. Immunol. Immunopathol. 53:1989;488-498.
35. Smyth J.M., Ortaldo J.R. Comparison of the effect of IL2 and IL6 on the lytic activity of purified human peripheral blood large granular lymphocytes. J. Immunol. 146:1991;1380-1384.
36. Song L., Kim Y.H., Chopra R.K., Proust J.J., Nagel J.E., Nordin A.A., Adler W.H. Age-related effects in T cell activation and proliferation. Exp. Gerontol. 28:1993;313-321.
37. Suematsu S., Matsuda T., Aozasa K., Akira S., Nakano N., Ohno S., Miyazaki J.I., Yamamura K.I., Hirano T., Kishimoto T. IgG1 plasmocytosis in interleukin 6 transgenic mice. Proc. Natl. Acad. Sci. USA. 86:1989;7547-7551.
38. Sun W.H., Binkley N., Bidwell D.W., Ershler W.B. The influence of recombinant interleukin-6 on blood and immune parameters in middle-aged and old rhesus monkeys. Lymphokine Cytokine Res. 12:1993;449-455.
39. Taga T., Kishimoto T. Gp130 and the interleukin-6 family of cytokines. Annu. Rev. Immunol. 15:1997;797-819.
40. Takasuki F., Okano A., Suzuki C., Chiela R., Takahara Y., Hirano T., Kishimoto T., Hamuro J., Akiyama Y. Human recombinant IL6/b cell stimulator factor 2 augments murine antigen-specific antibody responses in vitro and in vivo. J. Immunol. 141:1988;3072-3077.
41. Trebilkock A., Ponnappan U.U. Evidence for lowered induction of nuclear factor kappa B in activated human T lymphocytes during aging. Gerontology. 42:1996;137-146.
42. Wei J., Xu H., Davies J.L., Hemmings G.P. Increase of plasma IL-6 concentration with age in healthy subjects. Life Sci. 51:1993;1953.
43. Whisler R.L., Beiqing L., Chen M. Age-related decreases in IL-2 production by human T cells are associated with impaired activation of nuclear transcriptional factors AP-1 and NF-AT. Cell. Immunol. 169:1996;185-195.
44. Winchurch R.A., Birmingham W., Hilberg C., Munster A. Effect of endotoxin on immunity in aging mice. Cell. Immunol. 67:1982;384-389.
45. Woloski B.M.R.N.J., Smith E.M., Meyer W.J., Fuller G.M., Blalock J.E. Corticotropin-releasing activity of monokines. Science. 230:1985;1035.
46. Yancik R., Ries L.G. Cancer in the aged. Cancer. 68 (suppl):1991;2502-2510.